Singapore Exchange · Healthcare
Invest in Vicplas International stock from India
Indian and foreign residents can buy Vicplas International (569) shares directly through Paasa.
By Paasa · Updated
Vicplas International at a glance
- Price
- S$0.09+S$0.00 (0.00%)
- Market cap
- S$44.97M
- Day range
- S$0.09 – S$0.09
- P/E
- -8.80
- Dividend yield
- None
- Volume
- 300.00
- 1 month
- +31.34%
- 6 months
- +1.15%
- YTD
- -3.30%
- 1 year
- -4.35%
- 5 years
- -60.00%
Vicplas International statements, FY2022–FY2026
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | S$127.3M | S$120.8M | S$102.4M | S$129.2M | S$130.8M |
| Gross profit | S$15.6M | S$66.6M | S$52.4M | S$66.2M | S$68.1M |
| Operating income | −S$6.4M | S$27.0M | −S$4.9M | S$4.0M | S$6.0M |
| Net income | −S$5.1M | −S$2.4M | −S$1.4M | S$4.2M | S$8.8M |
| Earnings per share | −S$0.01 | −S$0.00 | −S$0.00 | S$0.01 | S$0.02 |
| EBITDA | S$2.0M | S$7.0M | S$6.9M | S$13.2M | S$17.9M |
| Total assets | S$147.7M | S$137.7M | S$131.5M | S$119.0M | S$130.3M |
| Total debt | S$48.4M | S$41.1M | S$32.5M | S$17.6M | S$28.0M |
| Cash and short-term investments | S$5.9M | S$4.7M | S$5.0M | S$8.6M | S$8.9M |
| Shareholders' equity | S$67.6M | S$71.4M | S$74.6M | S$78.6M | S$78.3M |
| Operating cash flow | S$1.4M | S$388.0K | S$6.7M | S$17.9M | S$10.3M |
| Free cash flow | −S$4.0M | −S$6.0M | −S$7.8M | S$12.5M | −S$2.6M |
| Capital expenditure | −S$5.4M | −S$6.4M | −S$14.5M | −S$5.3M | −S$12.9M |
Fiscal years as reported, the latest ending 31 Jul 2026. Figures in SGD; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Embracing Future | 8YY.SI | S$0.03 | S$58.94M |
| HC Surgical Specialists | 1B1.SI | S$0.36 | S$55.22M |
| Singapore Institute of Advanced Medicine | 9G2.SI | S$0.03 | S$48.27M |
| UG Healthcare | 8K7.SI | S$0.08 | S$48.03M |
| Cordlife | P8A.SI | S$0.12 | S$31.01M |
| Medi Lifestyle | Z4D.SI | S$0.05 | S$30.06M |
| Niks Professional | NPL.SI | S$0.23 | S$29.90M |
| Medinex | OTX.SI | S$0.20 | S$26.64M |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in Vicplas International from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to SGD when you buy.
Step 3
Search 569 and buy
Find Vicplas International by name or by its ticker, 569, and place your order.
Why invest in Vicplas International from India
What Vicplas International does
Vicplas International Ltd, established in Singapore in 1993, operates as an investment holding company with key business segments in medical devices and piping systems. The company's geographical reach includes Singapore, Malaysia, the People's Republic of China, and the United Kingdom. Vicplas International operates in the Medical - Devices industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Vicplas International stock from India?
Yes. Indian residents and NRIs can buy Vicplas International (569) shares directly through Paasa. Vicplas International is listed on the Singapore Exchange, in the Medical - Devices industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
How are Vicplas International dividends taxed for Indian investors?
Vicplas International does not currently pay a dividend, so there is nothing to withhold or declare today. If it starts paying one, singapore levies 0% withholding tax on dividends from resident companies, and dividends are taxed at your slab rate in India.
What tax do I pay in India when I sell Vicplas International shares?
Singapore does not levy capital gains tax on the sale of shares, ETFs or REITs. In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the SGD/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.
Would my heirs owe estate tax on Vicplas International shares?
Singapore imposes no estate or inheritance tax on listed securities. That is the source-country side; the shares themselves pass on like any other asset you hold in your own name.